메뉴 건너뛰기




Volumn 645, Issue , 2009, Pages 81-86

Novel therapeutic approach targeting the HIF-HRE system in the kidney

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLOR 3 HYDROXYCHINOLIN 2 CARBONIC ACID N CARBOXYMETHYLAMID; ADENOVIRUS VECTOR; COBALT; ENZYME INHIBITOR; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MIMOSINE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL HYDROXYLASE 2; S 956711; UNCLASSIFIED DRUG; HYPOXIA INDUCIBLE FACTOR 1;

EID: 61849083011     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-85998-9_13     Document Type: Conference Paper
Times cited : (5)

References (26)
  • 1
    • 33645452371 scopus 로고    scopus 로고
    • Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure
    • M. Nangaku, Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure, J. Am. Soc. Nephrol. 17(1), 17-25(2006)
    • (2006) J. Am. Soc. Nephrol. , vol.17 , Issue.1 , pp. 17-25
    • Nangaku, M.1
  • 2
    • 9644291798 scopus 로고    scopus 로고
    • Hypoxia in renal disease with proteinuria and/or glomerular hypertension
    • T. Tanaka, T. Miyata, R. Inagi, T. Fujita, and M. Nangaku, Hypoxia in renal disease with proteinuria and/or glomerular hypertension. Am. J. Pathol. 165(6), 1979-92(2004) (Pubitemid 39578376)
    • (2004) American Journal of Pathology , vol.165 , Issue.6 , pp. 1979-1992
    • Tanaka, T.1    Miyata, T.2    Inagi, R.3    Fujita, T.4    Nangaku, M.5
  • 3
    • 0042879795 scopus 로고    scopus 로고
    • Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension
    • DOI 10.1007/s00125-003-1155-z
    • F. Palm, J. Cederberg, P. Hansell, P. Liss, and P. O. Carlsson, Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension, Diabetologia. 46(8), 1153-60(2003) (Pubitemid 37041246)
    • (2003) Diabetologia , vol.46 , Issue.8 , pp. 1153-1160
    • Palm, F.1    Cederberg, J.2    Hansell, P.3    Liss, P.4    Carlsson, P.-O.5
  • 8
    • 0038163900 scopus 로고    scopus 로고
    • Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury
    • DOI 10.1161/01.CIR.0000078635.89229.8A
    • Z. Cai, D. J. Manalo, G. Wei, E. R. Rodriguez, K. Fox-Talbot, H. Lu, J. L. Zweier, and G. L. Semenza GL, Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury, Circulation. 108(1), 79-85(2003) (Pubitemid 36859024)
    • (2003) Circulation , vol.108 , Issue.1 , pp. 79-85
    • Cai, Z.1    Manalo, D.J.2    Wei, G.3    Rodriguez, E.R.4    Fox-Talbot, K.5    Lu, H.6    Zweier, J.L.7    Semenza, G.L.8
  • 13
    • 34547905406 scopus 로고    scopus 로고
    • Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system
    • Epub ahead of print
    • K. Takeda, A. Cowan, and G. H. Fong, Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system, Circulation. [Epub ahead of print] (2007)
    • (2007) Circulation.
    • Takeda, K.1    Cowan, A.2    Fong, G.H.3
  • 15
    • 33947727879 scopus 로고    scopus 로고
    • Use of a constitutively active hypoxia-inducible factor-1α transgene as a therapeutic strategy in no-option critical limb ischemia patients: Phase I dose-escalation experience
    • DOI 10.1161/CIRCULATIONAHA.106.607994
    • S. Rajagopalan, J. Olin, S. Deitcher, A. Pieczek, J. Laird, P. M. Grossman, C. K. Goldman, K. McEllin, R. Kelly, and N. Chronos, Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience, Circulation. 115(10), 1234-43(2007) (Pubitemid 46594767)
    • (2007) Circulation , vol.115 , Issue.10 , pp. 1234-1243
    • Rajagopalan, S.1    Olin, J.2    Deitcher, S.3    Pieczek, A.4    Laird, J.5    Grossman, P.M.6    Goldman, C.K.7    McEllin, K.8    Kelly, R.9    Chronos, N.10
  • 16
    • 2342506640 scopus 로고
    • The use of cobaltous chloride in the anemia associated with chronic renal disease
    • H. F. Gardner, The use of cobaltous chloride in the anemia associated with chronic renal disease. J. Lab. Clin. Med. 41(1), 56-64(1953)
    • (1953) J. Lab. Clin. Med. , vol.41 , Issue.1 , pp. 56-64
    • Gardner, H.F.1
  • 19
    • 25144475141 scopus 로고    scopus 로고
    • Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model
    • DOI 10.1038/labinvest.3700328, PII 3700328
    • T. Tanaka, I. Kojima, T. Ohse, J. R. Ingelfinger, S. Adler, T. Fujita, and M. Nangaku, Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model, Lab. Invest. 85(10), 1292-1307(2005) (Pubitemid 41348643)
    • (2005) Laboratory Investigation , vol.85 , Issue.10 , pp. 1292-1307
    • Tanaka, T.1    Kojima, I.2    Ohse, T.3    Ingelfinger, J.R.4    Adler, S.5    Fujita, T.6    Nangaku, M.7
  • 21
    • 32844456187 scopus 로고    scopus 로고
    • Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis
    • DOI 10.1111/j.1523-1755.2005.00742.x, PII 4495615
    • T. Tanaka, M. Matsumoto, R. Inagi, T. Miyata, I. Kojima, T. Ohse, T. Fujita, and M. Nangaku, Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis, Kidney Int. 68(6), 2714-2725(2005) (Pubitemid 43251016)
    • (2005) Kidney International , vol.68 , Issue.6 , pp. 2714-2725
    • Tanaka, T.1    Matsumoto, M.2    Inagi, R.3    Miyata, T.4    Kojima, I.5    Ohse, T.6    Fujita, T.7    Nangaku, M.8
  • 23
    • 34248642266 scopus 로고    scopus 로고
    • Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance
    • DOI 10.1111/j.1748-1716.2007.01676.x
    • H. Kasiganesan, V. Sridharan, and G. Wright, Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance, Acta Physiol. (Oxf). 190(2), 163-9(2007) (Pubitemid 46776396)
    • (2007) Acta Physiologica , vol.190 , Issue.2 , pp. 163-169
    • Kasiganesan, H.1    Sridharan, V.2    Wright, G.3
  • 26
    • 28844470450 scopus 로고    scopus 로고
    • Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues
    • DOI 10.1111/j.1365-2559.2005.02280.x
    • E. J. Soilleux, H. Turley, Y. M. Tian, C. W. Pugh, K. C. Gatter, and A. L. Harris AL, Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues, Histopathology. 47(6), 602-610(2005) (Pubitemid 41775183)
    • (2005) Histopathology , vol.47 , Issue.6 , pp. 602-610
    • Soilleux, E.J.1    Turley, H.2    Tian, Y.M.3    Pugh, C.W.4    Gatter, K.C.5    Harris, A.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.